Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12614001067662Phase 2Active, not recruiting
Phase 2, open-label trial of albendazole in cysticercosis and Soil-Transmitted Helminthiases (STH), sponsored by Australian Centre for Disease Preparedness. Started Oct 2013; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12614001067662.